Skip to Content

WATSON 782 (Diethylpropion Extended-Release 75 mg)

Pill imprint WATSON 782 has been identified as Diethylpropion hydrochloride extended-release 75 mg.

Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Diethylpropion hydrochloride extended-release 75 mg WATSON 782  Front
Diethylpropion hydrochloride extended-release 75 mg WATSON 782  Back
Diethylpropion hydrochloride extended-release 75 mg WATSON 782
Discount Card Promo
Diethylpropion hydrochloride extended-release
Imprint:
WATSON 782
Strength:
75 mg
Color:
White
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Anorexiants
CNS stimulants
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0782
Inactive Ingredients:
carbomer 934
mannitol
povidone
tartaric acid
zinc stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-0396 A-S Medication Solutions, LLC (repackager)
54868-1463 Physicians Total Care Inc (repackager)
66336-0689 Dispensing Solutions Inc. (repackager)
49999-0457 Lake Erie Medical and Surgical Supply (repackager)
21695-0876 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide